Loading...
Data remain limited on the long-term immune benefit of early initiation of antiretroviral therapy (ART) for HIV infection, including whether key immune parameters can match those of uninfected persons. In this study, longitudinal CD4 and CD8 cell counts for about 60,000 HIV+ individuals were compared with reference values derived from 2300 HIV-negative persons. A focus for the cross-sectional analysis was whether CD4 and CD8 counts reached the reference values when ART was started with a CD4 count >500 cells/mm3.
After 8 years of suppressive ART, only the individuals who started ART at CD4 cell counts >500 cells/mm3 reached the median reference CD4 count (830 cells/mm3 for men, 1005 cells/mm3 for women). CD8 cell counts decreased after start…